Red X iconGreen tick iconYellow tick icon

Deputy Dean, University of Otago, Christchurch

Associate Dean (Medical Admissions), Otago Medical School

Suetonia PalmerMB ChB, PhD, FRACP

Email suetonia.green@otago.ac.nz
Tel +64 3 3640 640

Suetonia Green is a graduate of the University of Otago, and is a kidney specialist and Professor at the University of Otago, Christchurch, New Zealand.

She is a Fellow of the Royal Society of New Zealand, Rutherford Discovery Fellow (2014–2019) and a L'Oréal For Women in Science Fellow (2013). Christchurch. She received a Gold Medal for Research at the University of Otago in 2018.

She is a qualified physician who received her Fellowship of the Royal Australasian College of Physicians in 2006 and completed her PhD in Medicine in 2010. She received a postdoctoral fellowship to complete two years of study at study at Harvard Medical School until 2011.

She has published over 200 peer-reviewed journal papers including in the New England Journal of Medicine, The Lancet, JAMA and the Annals of Internal Medicine.

Teaching

  • Co-convenor, 6th year programme Hauora Māori
  • Teacher, 4th year programme, Hauora Māori orientation wānanga

Affiliations

  • Royal Society of New Zealand
  • Australia and New Zealand Society of Nephrology
  • Scientific Programme and Awards Committee, Australia and New Zealand Society of Nephrology
  • Australasian Kidney Trials Network

Research interests

  • Clinical trials of new treatments for kidney disease
  • Symptom management of kidney diseases
  • Equitable healthcare delivery

Publications

Ha, J., Hiremath, S., Jun, M., Palmer, S., Wheeler, D., Coyne, D., … Badve, S. (2024). Long-term safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease: A systematic review and meta-analysis of randomized trials. Kidney International Reports, 9(4, Suppl.), WCN24-2313 . doi: 10.1016/j.ekir.2024.02.1183

Natale, P., Palmer, S. C., Jaure, A., Saglimbene, V., Iannone, A., Sluiter, A., … Strippoli, G. F. M. (2024). Blood pressure lowering for kidney transplant recipients: Systematic review with network meta-analysis. Journal of Hypertension. Advance online publication. doi: 10.1097/HJH.0000000000003663

Natale, P., Palmer, S. C., Ruospo, M., Longmuir, H., Dodds, B., Prasad, R., … Strippoli, G. F. M. (2024). Anticoagulation for people receiving long-term haemodialysis (Review). Cochrane Database of Systematic Reviews, 1, CD011858. doi: 10.1002/14651858.CD011858.pub2

Landers, A., Pitama, S. G., Green, S. C., & Beckert, L. (2023). ‘People that suffer or have been through it know the answers’: Stakeholders’ perspectives on improving healthcare systems for end-of-life care in chronic obstructive pulmonary disease. BMC Health Services Research, 23, 1443. doi: 10.1186/s12913-023-10431-9

Tunnicliffe, D. J., Palmer, S. C., Cashmore, B. A., Saglimbene, V. M., Krishnasamy, R., Lambert, K., … Strippoli, G. F. M. (2023). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis (Review). Cochrane Database of Systematic Reviews, 11, CD007784. doi: 10.1002/14651858.CD007784.pub3

Back to top